Article

CBER Recall of Hepatitis A Vaccine

Author(s):

BioPharm International Editors

CBER Recall of Hepatitis A Vaccine, Inactivated (VAQTA) Packaged in single-dose prefilled syringes, posted 10 December 2001

Newsletter

Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.

Subscribe Now!
Related Videos
Behind the Headlines, Episode 23: Patent Cliff Deals, Tariff Pressures, and the In Vivo Cell Therapy Bet
Related Content
Ampoules vaccine from coronavirus with syringe 3d render illustration on white. | Image Credit: © mylisa - © mylisa - stock.adobe.com
August 28th 2025

FDA Approves Moderna’s Updated COVID-19 Vaccines Targeting LP.8.1 Variant

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game
August 28th 2025

The Future of Cleanroom Construction: How Hybrid Solutions are Changing the Game

G-CON
A hand is placing the final wooden block with a green certificate checkmark, symbolizing achievement, quality assurance and completion, against a plain pastel blue background. | Image credit: TimmyTimTim – stock.adobe.com
August 28th 2025

Continued Process Verification Is Critical in Pharmaceutical Manufacturing

Philip Hoersch
Mastering Antibody-Drug Conjugates
August 28th 2025

Mastering Antibody-Drug Conjugates

BIOVECTRA
Your Voice in Biopharma's Digital Shift: Manufacturing & Tech Adoption Survey
August 28th 2025

Your Voice in Biopharma's Digital Shift: Manufacturing & Tech Adoption Survey

Christopher Cole
Document Review and Quality Control Concept. Document with a checkmark, quality assurance, and process control. auditing, compliance, verification, data inspection, and business workflow management. | Image Credit: © Supatman - stock.adobe.com
August 28th 2025

A Novel, Enhanced, and Sustainable Approach to Audit Trail Review

Diana Russo
© 2025 MJH Life Sciences

All rights reserved.